Advocacy intelligence hub — real-time data for patient organizations
Tryngolza: FDA approved
adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS)
Ikaria Bioscience Pty Ltd — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Redemplo
Arrowhead Pharmaceuticals, Inc.
Patient Assistance Programs1
Tryngolza
Ionis Pharmaceuticals
Redemplo
(plozasiran)Orphan drugArrowhead Pharmaceuticals, Inc.
Tryngolza
(olezarsen)Orphan drugIonis Pharmaceuticals
12.1 Mechanism of Action Olezarsen is an ASO-GalNAc 3 conjugate that binds to apoC-III mRNA leading to mRNA degradation and resulting in a reduction o...
Abhimanyu Garg, MD, MD
University of Texas Southwestern Medical Center
📍 DALLAS, TX
Philippe Moulin, MD
Hospices Civils de Lyon
YALIANG LI
CorrectSequence Therapeutics (Shanghai) Co., Ltd
Dong YOU
Visirna Therapeutics HK Limited
Christie M Ballantyne, MD
Baylor College of Medicine
📍 HOUSTON, TX
Archna Bajaj, MD
University of Pennsylvania
📍 PHILADELPHIA, PA